Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Neurocrine Biosciences, Inc.. A complete text table follows the diagram.
Net product sales dominate Neurocrine's quarter, with collaboration revenue remaining a small secondary stream.
Swipe to explore
Labels and displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Neurocrine Biosciences revenue | 1 | $815M | $814.5M reported quarterly revenue |
| Net product sales | 2 | $811M | 99.6% of total revenues |
| Collaboration revenues | 2 | $3.5M | Reported collaboration revenue |
| From | To | Value |
|---|---|---|
| Neurocrine Biosciences revenue | Net product sales | $811M |
| Neurocrine Biosciences revenue | Collaboration revenues | $3.5M |